By proceeding, you agree to our
Greetings! Welcome to the 2nd Annual Oligonucleotides CMC & Analytical Development Summit, focused on accelerating scalability and regulatory approval through tightened QC of oligos for cost-efficient GMP manufacturing. With the oligonucleotides market projected to reach $2 billion by 2027 and over 250 clinical phase drug developments, we aim to expand the potential of oligonucleotides beyond rare diseases and use them to treat large patient populations for undruggable targets.In the past year, significant progress has been made in the field, with Switch Therapeutics advancing its first RNAi technology, Avidity turbocharging its antibody-oligo conjugate, and Ansa Biotech synthesizing the world's longest oligonucleotide. However, drug developers still face challenges in manufacturability and the lack of concrete regulatory protocols. That's why the 2nd annual Oligonucleotides CMC & Analytical Development Summit brings together 70+ industry leaders in CMC and analytical development to share their expertise and thought leadership.
Learn about the current research and developments for cost-efficient GMP manufacturing .
Gather in-depth knowledge on emerging analytical characterization for oligonucleotides, short oligomers, regulatory guidance & partnering, and more.
Take part in insightful sessions to scale up your oligonucleotide with long-term manufacturability in mind–from cost considerations to commercial scale.
Hear from top industry experts to capitalize on the next generation of oligonucleotides for non-rare disease indications and future growth opportunities.
02-05 October 2023
CHI is excited to host its 15th Annual Immunogenicity & Bioassay Summit in Washington, D.C. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from the industry, academia and the regulatory
03-05 October 2023
The Becker's Chief Medical Information Officer Forum is an exclusive event that brings together top CMIOs from various healthcare organizations to discuss the latest trends, challenges, and opportunities in healthcare IT. The forum provides a unique
Join us at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit, where we bring together the brightest minds in biopharma and academia to revolutionize the treatment of eye diseases. This premier event is the nexus between groundbreaking precl
Join us at the 38th GS1 Healthcare Global Conference, where healthcare professionals from across the globe will converge to connect, collaborate, and exchange knowledge. This highly anticipated event serves as a platform for sharing experiences, lear
03-06 October 2023
The 8th Annual Becker's HIT + DH + RCM Conference: The Future of Business and Clinical Technologies is a premier healthcare event that brings together over 2500 executive-level attendees from the healthcare industry. This conference serves as a platf
The Becker's Patient Experience + Digital Marketing Forum is a premier event for healthcare executives, marketing professionals, and patient experience leaders who are looking to stay at the forefront of patient engagement and digital marketing strat
04-05 October 2023
The Becker's CIO + CDO Forum is an exclusive event that brings together leading CIOs and CDOs from health systems across the U.S. to discuss the latest trends, challenges, and opportunities in the rapidly evolving digital landscape. The forum provide
Future Labs Live USA is a leading event focused on the future of laboratories with over 150+ speakers from the world’s leading laboratories, and 1000+ attendees from around the world. Start-ups and disruptors will meet lab heads and lab techs togethe
04-06 October 2023
Making sense of your data is key for every modern predictive business. At ML Conference you will develop a deep understanding of your data, as well as learn about the latest tools and technologies. Learn from leading experts about which methods, libr
05-05 October 2023
Explore the prominent challenges and opportunities in the utilization and integration of AI, ML and Data Science within pharmaceutical clinical development and trials. Participate in and shape critical conversations covering topics such as AI-enabled
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
It was my first time there, and I was quite pleased with the quality of the talks.
Overall, I think it's a good conference, especially for people new to the area. It has been a good experience.
WuXi STA, a WuXi AppTec company, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with four sites in China and two sites in the United States and one in Europe.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.